Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 8/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.39 |
| ▸ | GPR55 | Q9Y2T6 | 4/20 | 0.37 |
| ▸ | MET | P08581 | 3/20 | 0.33 |
| ▸ | CLK1 | P49759 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31489224 | 1.00 | CREBBP (0.39) | CREBBPCYP17A1GPR55METCLK1 | |
| SCHEMBL31489764 | 0.83 | CREBBP (0.51) | CREBBP | |
| SCHEMBL31489905 | 0.83 | CREBBP (0.51) | CREBBP | |
| SCHEMBL31489456 | 0.83 | PDE2A (0.37) | CREBBP | |
| SCHEMBL31489672 | 0.83 | PDE2A (0.37) | CREBBP | |
| SCHEMBL24783582 | 0.81 | CYP17A1 (0.43) | CREBBPCYP17A1GPR55METCLK1 | |
| SCHEMBL31489479 | 0.81 | CREBBP (0.52) | CREBBPDYRK1A | |
| SCHEMBL31489752 | 0.81 | CREBBP (0.52) | CREBBPDYRK1A | |
| SCHEMBL24783581 | 0.81 | CYP17A1 (0.43) | CREBBPCYP17A1GPR55METCLK1 | |
| SCHEMBL26509021 | 0.81 | CYP17A1 (0.43) | CREBBPCYP17A1GPR55METCLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072395-A1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-03 | — | — | WO | disclosed |